AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2940953 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (200 mg) + Ipratropium bromide (200 micrograms)
Number of subjects: 9
Study 2940953 — intervention group
Group type: COMPARATOR
Intervention: Cromolyn sodium (200 mg)
Number of subjects: 9
Study 2940953 — intervention group
Group type: COMPARATOR
Intervention: Atropine sulfate (2.0 mg)
Number of subjects: 9
Study 2940953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2940953 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide (200 micrograms)
Number of subjects: 9
Study 31014520 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Coagulum (BC)
Number of subjects: 32
Study 31014520 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Allograft (AL)
Number of subjects: 32
Study 31014520 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine Bone (BB)
Number of subjects: 32
Study 30104327 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive telephone reminder
Number of subjects: 629
Study 30104327 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service reminder (SMS)
Number of subjects: 629
Study 30104327 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional interventions)
Number of subjects: 629
Study 27436469 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced therapy (doxycycline and ceftriaxone)
Number of subjects: 69
Study 27436469 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (benzathine penicillin G)
Number of subjects: 69
Study 25193534 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose UPA-CVR (1500 μg/day)
Number of subjects: 55
Study 25193534 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose UPA-CVR (2500 μg/day)
Number of subjects: 55
Study 25193534 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel (LNG) 1.5 mg orally
Number of subjects: 55
Study 22994618 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical therapy once a month for 6 months, along with educational support, counselling and audiovisual materials
Number of subjects: 60
Study 22994618 — intervention group
Group type: COMPARATOR
Intervention: Standard care rehabilitation as prescribed by a physician and educational materials upon discharge from hospital
Number of subjects: 60
Study 20353316 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior change counseling intervention (2 h workshop)
Number of subjects: 35
Study 20353316 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 35
Study 18396455 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) 200 mg/day for 8 weeks
Number of subjects: 15
Study 16317827 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast
Number of subjects: 0
Study 12356154 — intervention group
Group type: EXPERIMENTAL
Intervention: CoStasis (collagen-based composite)
Number of subjects: 53
Study 12356154 — intervention group
Group type: COMPARATOR
Intervention: Collagen sponge with manual pressure (control)
Number of subjects: 53
Study 10400099 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C-octanoic acid breath test
Number of subjects: 28
Study 8548959 — intervention group
Group type: EXPERIMENTAL
Intervention: Merocel nasal tampons
Number of subjects: 50
Study 8548959 — intervention group
Group type: COMPARATOR
Intervention: BIPP (Bismuth Subnitrate and Iodoform Paste)
Number of subjects: 50
Study 2293047 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasonography after lumbar puncture
Number of subjects: 36
Study 2293047 — intervention group
Group type: COMPARATOR
Intervention: Transcranial Doppler ultrasonography before lumbar puncture
Number of subjects: 36
Study 7269016 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine enema (P.I.E.)
Number of subjects: 40
Study 7269016 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving P.I.E.)
Number of subjects: 40
Study 29691649 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive interference control training
Number of subjects: 88
Study 29691649 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 88
Study 28343558 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator group (n=9)
Number of subjects: 18
Study 28343558 — intervention group
Group type: COMPARATOR
Intervention: Real patient group (n=9)
Number of subjects: 18
Study 28343558 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall score improvement (all trainees)
Number of subjects: 18
Study 28343558 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator group (very unconfident trainees)
Number of subjects: 18
Study 28343558 — intervention group
Group type: COMPARATOR
Intervention: Patient group (very unconfident trainees)
Number of subjects: 18
Study 26373569 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide long-acting repeatable (LAR)
Number of subjects: 196
Study 23635309 — intervention group
Group type: EXPERIMENTAL
Intervention: High Volume (HV) exercise (200-300 minutes/week)
Number of subjects: 90
Study 23635309 — intervention group
Group type: COMPARATOR
Intervention: Low Volume (LV) exercise (<150 minutes/week)
Number of subjects: 90
Study 20615504 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored cardiac rehabilitation program
Number of subjects: 225
Study 20615504 — intervention group
Group type: COMPARATOR
Intervention: Traditional cardiac rehabilitation program
Number of subjects: 225
Study 19763700 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI (per 10 kg/m² increase)
Number of subjects: 238
Study 19763700 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI (after adjustment for age and gender)
Number of subjects: 238
Study 17338717 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy in patients with CKD
Number of subjects: 229
Study 17338717 — intervention group
Group type: COMPARATOR
Intervention: ICD therapy in patients without CKD
Number of subjects: 229
Study 17338717 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD as a predictor of death
Number of subjects: 229
Study 17338717 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in creatinine clearance
Number of subjects: 229
Study 15284015 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.5 mg total dose (three vials of SALon)
Number of subjects: 44
Study 15284015 — intervention group
Group type: EXPERIMENTAL
Intervention: 17.5 mg total dose (five vials of SALon)
Number of subjects: 44
Study 11876441 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg capsules
Number of subjects: 20
Study 11876441 — intervention group
Group type: COMPARATOR
Intervention: Tramal 50 mg capsules (control)
Number of subjects: 20
Study 9555559 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (Proscar)
Number of subjects: 182
Study 9555559 — intervention group
Group type: COMPARATOR
Intervention: Ex-placebo group
Number of subjects: 182
Study 7822587 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with a greater right-ear (left hemisphere) advantage
Number of subjects: 0
Study 7822587 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with a lower right-ear advantage
Number of subjects: 0
Study 7822587 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 0
Study 2893867 — intervention group
Group type: EXPERIMENTAL
Intervention: biosynthetic human growth hormone (BSHGH) 0.1 mg/kg daily for the first 7 postoperative days
Number of subjects: 11
Study 2893867 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 11
Study 29402675 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-by-month phones
Number of subjects: 81
Study 29402675 — intervention group
Group type: COMPARATOR
Intervention: Gift card compensation
Number of subjects: 81
Study 24934432 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing intervention
Number of subjects: 0
Study 24934432 — intervention group
Group type: COMPARATOR
Intervention: Neutral writing condition (control)
Number of subjects: 0
Study 25507175 — intervention group
Group type: EXPERIMENTAL
Intervention: IDeg-flex
Number of subjects: 1180
Study 25507175 — intervention group
Group type: COMPARATOR
Intervention: IDeg-evening
Number of subjects: 1180
Study 25507175 — intervention group
Group type: COMPARATOR
Intervention: IGlar
Number of subjects: 1180
Study 23036611 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 621
Study 23036611 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of eating awareness
Number of subjects: 621
Study 23036611 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall perceived stress and BMI
Number of subjects: 621
Study 20921837 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 0.5% (15 mg), morphine 0.4 mg, and fentanyl 15 μg
Number of subjects: 40
Study 20921837 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine 0.4 mg and fentanyl 15 μg
Number of subjects: 40
Study 18522937 — intervention group
Group type: EXPERIMENTAL
Intervention: I.V. ropivacaine
Number of subjects: 19
Study 18522937 — intervention group
Group type: COMPARATOR
Intervention: I.V. lidocaine
Number of subjects: 19
Study 15916853 — intervention group
Group type: EXPERIMENTAL
Intervention: IL1B ‐31C/‐511T alleles and homozygotes in sporadic simple FS patients
Number of subjects: 229
Study 15916853 — intervention group
Group type: COMPARATOR
Intervention: Control group (158 controls)
Number of subjects: 229
Study 12693656 — intervention group
Group type: EXPERIMENTAL
Intervention: FloSeal (FS)
Number of subjects: 20
Study 12693656 — intervention group
Group type: COMPARATOR
Intervention: Thrombin-soaked gelatin foam
Number of subjects: 20
Study 10482146 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus cilostazol
Number of subjects: 490
Study 10482146 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus ticlopidine
Number of subjects: 490
Study 8928187 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human insulin infused at 40 mU/m2/min for 2 hr
Number of subjects: 17
Study 8928187 — intervention group
Group type: COMPARATOR
Intervention: 10% xylitol infused at 100 ml/hr for 2 hr (control)
Number of subjects: 17
Study 1824218 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g salt per day diet (Group I)
Number of subjects: 32
Study 1824218 — intervention group
Group type: COMPARATOR
Intervention: 10 g salt per day diet (Group II)
Number of subjects: 32
Study 6787909 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium (G-I-K) infusion (300 gm of glucose, 50 units of insulin, and 80 mEq of KCl per liter at a rate of 1.5 ml/kg/hr for 48 hours)
Number of subjects: 24
Study 6787909 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 24
Study 31881241 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Caries Removal (SCR)
Number of subjects: 120
Study 31881241 — intervention group
Group type: COMPARATOR
Intervention: Total Caries Removal (TCR)
Number of subjects: 120
Study 30451318 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrronium tosylate (GT)
Number of subjects: 44
Study 30451318 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 44
Study 30211991 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged Garlic Extract (AGE)
Number of subjects: 151
Study 30211991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 27515154 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (250,000 IU vitamin-D3)
Number of subjects: 218
Study 27515154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 24335748 — intervention group
Group type: EXPERIMENTAL
Intervention: ED treatment after 12 weeks
Number of subjects: 362
Study 24335748 — intervention group
Group type: COMPARATOR
Intervention: Non-drug, run-in period (4 weeks)
Number of subjects: 362
Study 22194025 — intervention group
Group type: EXPERIMENTAL
Intervention: BrainLAB® mask with custom made bite‐block (fixation S)
Number of subjects: 16
Study 22194025 — intervention group
Group type: COMPARATOR
Intervention: BrainLAB® mask without custom made bite‐block (fixation A)
Number of subjects: 16
Study 22194025 — intervention group
Group type: COMPARATOR
Intervention: Homemade neck support with bite‐block (fixation B)
Number of subjects: 16
Study 19111269 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative radiotherapy technology
Number of subjects: 0
Study 19111269 — intervention group
Group type: COMPARATOR
Intervention: Historical examples of randomized trials
Number of subjects: 0
Study 17326837 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 pounds monetary incentive for completion of questionnaires
Number of subjects: 547
Study 17326837 — intervention group
Group type: COMPARATOR
Intervention: No monetary incentive (historical control)
Number of subjects: 547
Study 15197115 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg)
Number of subjects: 30
Study 15197115 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (20 mg)
Number of subjects: 30
Study 15197115 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study 11772834 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine (Group LB)
Number of subjects: 75
Study 11772834 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (Group L)
Number of subjects: 75
Study 11772834 — intervention group
Group type: COMPARATOR
Intervention: Air Control (Group C)
Number of subjects: 75
Study 9661598 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter paper blood spot assay for IGF-I
Number of subjects: 27
Study 9661598 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter paper blood spot assay for IGFBP-3
Number of subjects: 27
Study 9661598 — intervention group
Group type: COMPARATOR
Intervention: Filter paper procedures
Number of subjects: 27
Study 9661598 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of IGF-I and IGFBP-3 in paired plasma and dried blood spot extracts
Number of subjects: 27
Study 8567794 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. immunoglobulins (Ig)
Number of subjects: 34
Study 8567794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 2547617 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice on dietary factors including reduction in total fat and increase in polyunsaturated fat intake
Number of subjects: 2033
Study 2547617 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice on increasing fatty fish intake
Number of subjects: 2033
Study 2547617 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice on increasing cereal fibre intake
Number of subjects: 2033
Study 2547617 — intervention group
Group type: COMPARATOR
Intervention: No advice regarding dietary factors
Number of subjects: 2033
Study 308283 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (Solu-Medrol) before temporary cardiopulmonary bypass
Number of subjects: 150
Study 308283 — intervention group
Group type: COMPARATOR
Intervention: Control group (no methylprednisolone)
Number of subjects: 150
Study 31241527 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stabilization exercise
Number of subjects: 20
Study 31241527 — intervention group
Group type: COMPARATOR
Intervention: Standard hip muscle exercise (Control)
Number of subjects: 20
Study 29296854 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 26
Study 29296854 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CSA)
Number of subjects: 26
Study 24506693 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT) combined with mitomycin C (MMC)
Number of subjects: 55
Study 24506693 — intervention group
Group type: COMPARATOR
Intervention: Conjunctival autograft (CA) combined with mitomycin C (MMC)
Number of subjects: 55
Study 22673926 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir (Tamiflu®) 75 mg single dose
Number of subjects: 30
Study 22145462 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Insulin Response Diet (LIR)
Number of subjects: 86
Study 22145462 — intervention group
Group type: COMPARATOR
Intervention: Conventional Diet (CD)
Number of subjects: 86
Study 18996759 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable gastric banding with truncal vagotomy (LGBTV)
Number of subjects: 50
Study 18996759 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic adjustable gastric banding alone (LGB)
Number of subjects: 50
Study 16397182 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment
Number of subjects: 0
Study 15319103 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft prefabricated orthoses
Number of subjects: 874
Study 15319103 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft custom orthoses
Number of subjects: 874
Study 15319103 — intervention group
Group type: EXPERIMENTAL
Intervention: Semirigid biomechanical orthoses
Number of subjects: 874
Study 15319103 — intervention group
Group type: EXPERIMENTAL
Intervention: Semirigid prefabricated orthoses
Number of subjects: 874
Study 15319103 — intervention group
Group type: COMPARATOR
Intervention: All orthoses types
Number of subjects: 874
Study 10940701 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy alone
Number of subjects: 159
Study 10940701 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (radiotherapy with neoadjuvant cisplatin)
Number of subjects: 159
Study 10940701 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 159
Study 10940701 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 159
Study 9324707 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling service for patients under a case management trial scheme
Number of subjects: 0
Study 9324707 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 8258615 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide nasal spray (100 micrograms)
Number of subjects: 0
Study 8258615 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 0
Study 3910429 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia (G-II)
Number of subjects: 24
Study 3910429 — intervention group
Group type: COMPARATOR
Intervention: Standard anaesthesia (G-I)
Number of subjects: 24
Study 31275597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin (10 mg twice daily)
Number of subjects: 336
Study 31275597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study 29913001 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (2 infusions of 375 mg/m2)
Number of subjects: 120
Study 29913001 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus (along with tapering alternate-day prednisolone for 12 months)
Number of subjects: 120
Study 27150353 — intervention group
Group type: EXPERIMENTAL
Intervention: TM SPV (treadmill self-paced VO2max test)
Number of subjects: 13
Study 27150353 — intervention group
Group type: EXPERIMENTAL
Intervention: Bruce protocol
Number of subjects: 13
Study 27150353 — intervention group
Group type: EXPERIMENTAL
Intervention: CE SPV (cycle ergometer self-paced VO2max test)
Number of subjects: 13
Study 24913242 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative 1 mg morphine bolus (Group B)
Number of subjects: 48
Study 24913242 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative 2 mg morphine bolus (Group C)
Number of subjects: 48
Study 24913242 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural morphine infusion of 0.2 mg/h with 0.1% levobupivacaine via PCEA (all groups)
Number of subjects: 48
Study 24913242 — intervention group
Group type: COMPARATOR
Intervention: No intraoperative morphine loading (Group A)
Number of subjects: 48
Study 21300723 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal anchorage (Onplant or Orthosystem implant)
Number of subjects: 120
Study 21300723 — intervention group
Group type: COMPARATOR
Intervention: Headgear
Number of subjects: 120
Study 21300723 — intervention group
Group type: COMPARATOR
Intervention: Transpalatal bar
Number of subjects: 120
Study 19925489 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 61
Study 19925489 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 61
Study 19925489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 19171091 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 97
Study 19171091 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Burch colposuspension
Number of subjects: 97
Study 16227788 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz
Number of subjects: 334
Study 16227788 — intervention group
Group type: EXPERIMENTAL
Intervention: didanosine/stavudine
Number of subjects: 334
Study 16227788 — intervention group
Group type: EXPERIMENTAL
Intervention: nelfinavir
Number of subjects: 334
Study 16227788 — intervention group
Group type: COMPARATOR
Intervention: zidovudine/lamivudine
Number of subjects: 334
Study 12364844 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium (Depakote)
Number of subjects: 40
Study 10866044 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glucosamine infusion (1.6 micromol x min(‐1) x kg(‐1))
Number of subjects: 10
Study 10866044 — intervention group
Group type: EXPERIMENTAL
Intervention: High glucosamine infusion (5 micromol x min(‐1) x kg(‐1))
Number of subjects: 10
Study 10866044 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study 9174428 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg subcutaneous implant 4-6 weeks preoperatively (Group B)
Number of subjects: 60
Study 9174428 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg subcutaneous implant 4-6 weeks preoperatively and repeated on the day of endometrial resection (Group C)
Number of subjects: 60
Study 9174428 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group A, no preoperative preparation)
Number of subjects: 60
Study 9174428 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 60
Study 9174428 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B and C (combined)
Number of subjects: 60
Study 7910133 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% N-acetyl-aspartyl glutamic acid (NAAGA)
Number of subjects: 17
Study 7910133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17